{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.42","value":"70.9"},{"groupId":"OG001","spread":"1.59","value":"68.2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"292"},{"groupId":"OG001","value":"287"}],"units":"Participants"}],"description":"Mean quality of life score after 6 cycles of study treatment estimated from a mixed model. The FACT-O-TOI is composed of three subscales: Physical Well Being (PWB) (7 Items), Functional Well Being (FWB) (7 items), and Ovarian Cancer Subscale (OCS) (12 items). Each item in the FACT-O TOI are scored using a 5-point scale (0=not at all; 1=a little bit; 2=somewhat; 3=quite a bit; 4=very much). A subscale score is computed as long as more than 50% of subscale items have been answered. A Total score of the FACT-O TOI is the summation of the three subscale scores; if more than 80% of the FACT-O TOI items provide valid responses and all three subscales have valid scores. A score of the FACT-O TOI is ranged 0-104 with a larger score indicating a more preferred state of health-related quality of life (HRQOL)","dispersionType":"Standard Error","groups":[{"description":"Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses.\n\nBevacizumab: Given IV\n\nCarboplatin: Given IV\n\nComputed Tomography: Correlative studies\n\nPaclitaxel: Given IV","id":"OG000","title":"Arm I (Adjuvant Chemotherapy Suboptimally Debulked)"},{"description":"Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses. Patients undergo interval cytoreductive surgery between courses 3 and 4.\n\nBevacizumab: Given IV\n\nCarboplatin: Given IV\n\nComputed Tomography: Correlative studies\n\nPaclitaxel: Given IV\n\nTherapeutic Conventional Surgery: Undergo surgery","id":"OG001","title":"Arm II (Neoadjuvant Chemotherapy)"}],"paramType":"MEAN","populationDescription":"All individuals who did not opt for neo-adjuvant treatment and completed a baseline FACT-O TOI assessment and at least one follow-up assessment.","reportingStatus":"POSTED","timeFrame":"18 weeks after enrolling on the study, which is the time it takes to complete 6 cycles of treatment plus 3 weeks","title":"Quality of Life Score as Measured by Functional Assessment of Cancer Therapy-Ovary-Total Outcome Index (Fact-O TOI)","type":"SECONDARY","unitOfMeasure":"Units on a Scale"}